NPs can be engineered to recognize and bind to specific molecules overexpressed on the surface of HCC cells, such as glypican-3 (GPC3), a proteoglycan highly expressed in HCC but not in normal liver tissue [98]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.